1. Chandra Praveen
2. Goel Rohit
3. Chouhan Nagender S

9789386261953

10.5005/jp/books/13034_89

1/e

2017

3

1. Medanta—The Medicity, Gurgaon, Haryana, India, Medanta – The Medicity, Gurugram, Haryana, India, Division of Interventional Cardiology and Structural Heart, New Delhi, India, Medanta—The Medicity, Gurugram, Haryana, India; Medanta Moolchand Heart Institute, New Delhi, India, Medanta Heart Institute, Medanta—The Medicity, Gurugram, Haryana, India, National Interventional Council (NIC), Cardiological Society of India; Medanta–The Medicity, Gurugram, Haryana, India, Heart Institute, Medanta Super Speciality Hospital, Gurugram, Haryana, India, Medanta—The Medicity, Gurugram, Haryana, India, Medanta Moolchand Heart Institute, Delhi, India, Medanta: The Medicity, Gurgaon, Haryana, India; NIC-2014–15, Medanta—The Medicity, Gurugram, Haryana, India, Medanta–The Medicity, Gurugram, Haryana, India, Medanta Heart Institute, Medanta—The Medicity, Gurgaon, Haryana, India, Medanta—The Medicity, Haryana, India, Cardiological Society of India; Medanta–The Medicity, Gurgaon, Haryana, India, Medanta Med
2. Medanta Heart institute, Medanta–the Medicity, Gurugram, Haryana, India, Medanta—The Medicity, Gurugram, Haryana, India
3. Medanta Heart Institute, Medanta–The Medicity, Gurugram, Haryana, India

Apixaban, stroke, nonvalvular atrial fibrillation, AF, warfarin, vitamin K antagonist, VKA, pharmacokinetic, newer oral anticoagulant, NOAC